advertising
-
1
Tremont-Lukats IW, Megeff C, Backonja MM: Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. .Drugs 60::1029. ,2000. .
-
2
Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. .Pain 83::389. ,1999. .
-
3
Oates PJ, Mylari BL: Aldose reductase inhibitors: therapeutic implications for diabetic complications. .Expert Opin Investig Drugs 8::2095. ,1999. .
-
4
Sosenko JM, Sparling YH, Hu D, et al: Use of the Semmes-Weinstein monofilament in the strong heart study: risk factors for clinical neuropathy. .Diabetes Care 22::1715. ,1999. .
-
5
Olmos PR, Cataland S, O’Dorisio TM, et al: The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. .Am J Med Sci 309::76. ,1995. .
-
6
Horwitz LR, Burke TJ, Carnegie D: Augmentation of wound healing using monochromatic infrared energy: exploration of a new technology for wound management. .Adv Wound Care 12::35. ,1999. .
-
7
Sacco IC, Amadio AC: A study of biomechanical parameters in gait analysis and sensitive cronaxie of diabetic neuropathic patients. .Clin Biomech 15::196. ,2000. .
-
8
Kumar S, Fernando DJ, Veres A, et al: Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk for foot ulceration. .Diabetes Res Clin Pract 13::63. ,1991. .
-
9
Mayfield JA, Sugarman JR: The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. .J Fam Pract 49 (suppl 11)::S17. ,2000. .
-
10
Hrobjartsson A, Gotzsche PC: Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. .N Engl J Med 344::1594. ,2001. .
-
11
Matsunaga K, Furchgott RF: Interactions of light and sodium nitrite in producing relaxation of rabbit aorta. .J Pharmacol Exp Ther 248::687. ,1989. .
-
12
Maegawa Y, Itoh T, Hosokawa T, et al: Effects of near-infrared low-level laser irradiation on microcirculation. .Lasers Surg Med 27::427. ,2000. .
-
13
Chen LY, Mehta JL: Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. .J Cardiovasc Pharmacol 32::57. ,1998. .
-
14
Jia L, Bonaventura C, Bonaventura J, et al: S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. .Nature 380::221. ,1996. .
-
15
Djibladze MI, Melikishvili ZG, Uchaneishvili SD: Laser therapy by noncoherent light field of radiation. .Biomed Sci Instrum 34::235. ,1997. .
-
16
Burke TJ, Page BT, Vail C, et al: Increase in serum nitric oxide induced by near infrared phototherapy (NIP). Assoc Equine Sports Medicine. 20th Annual Meeting, September 6, 2000..
-
17
Padron J, Peiro C, Cercas E, et al: Enhancement of S-nitrosylation in glycosylated hemoglobin. .Biochem Biophys Res Commun 271::217. ,2000. .
-
18
Martina V, Bruno GA, Trucco F, et al: Platelet cNOS activity is reduced in patients with IDDM and NIDDM. .Thromb Haemost 79::520. ,1998. .
-
19
Boykin J: The nitric oxide connection: hyperbaric oxygen therapy, becaplermin, and diabetic ulcer management. .Adv Skin Wound Care 13::169. ,2000. .
Symptomatic Reversal of Peripheral Neuropathy in Patients with Diabetes
Search for other papers by Alan B. Kochman in
Current site
Google Scholar
PubMed
Search for other papers by Dale H. Carnegie in
Current site
Google Scholar
PubMed
Search for other papers by Thomas J. Burke in
Current site
Google Scholar
PubMed
Forty-nine consecutive subjects with established diabetic peripheral neuropathy were treated with monochromatic near-infrared photo energy (MIRE) to determine if there was an improvement of sensation. Loss of protective sensation characterized by Semmes-Weinstein monofilament values of 4.56 and above was present in 100% of subjects (range, 4.56 to 6.45), and 42 subjects (86%) had Semmes-Weinstein values of 5.07 or higher. The ability to discriminate between hot and cold sensation was absent (54%) or impaired (46%) in both groups prior to the initiation of MIRE treatment. On the basis of Semmes-Weinstein monofilament values, 48 subjects (98%) exhibited improved sensation after 6 treatments, and all subjects had improved sensation after 12 treatments. Therefore, MIRE may be a safe, drug-free, noninvasive treatment for the consistent and predictable improvement of sensation in diabetic patients with peripheral neuropathy of the feet. (J Am Podiatr Med Assoc 92(3): 125-130, 2002)
advertising
advertising
